A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2004 by Genentech, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Genentech, Inc.
ClinicalTrials.gov Identifier:
NCT00097487
First received: November 24, 2004
Last updated: June 23, 2005
Last verified: November 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given